These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2005-002323-14||Samanburður á þremur meðferðum við áreynsluþvagleka.||bad-data|
|Not reported||2005-005438-11||Lipid-lowering effects of ACTH||2007-10-10||due-trials|
|Ongoing||2005-005928-13||Prospective randomized double blind trial on the use of Scopoderm patch for control of post-operative nausea and vomitting in patients undergoing gynecologic laparoscopic procedures.||not-yet-due|
|Not reported||2006-003799-36||Effects of alcohol on brain function and autonomic nerves||2007-10-10||due-trials|
|Not reported Terminated||2007-000627-17||Serum profiles of paracetamol and glutathione after high doses of paracetamol for 6 days||2012-09-09||due-trials|
|Listed as ongoing, but also has a completion date||2008-003235-20||NOPHO - ALL 2008||2016-04-03||bad-data|
|Not reported||2010-021842-23||A randomized clinical trial of the effects of Tea tree essential oil on adult leg cellulitis of class II in the Eron/Dall classification system for cellulitis: Pilot study.||2011-05-16||due-trials|
|Not reported||2012-005216-26||A study of the effect of monocaprin in dental adhesive/dental gel on Candida infection in the oral cavity||2014-06-30||due-trials|
|Not reported||2013-000975-33||Novel Assays for the Determination of Urinary 2,8-Dihydroxyadenine and Other Key Urinary Purine Metabolites - Rare Diseases Clinical Research Network||2015-05-31||due-trials|
|Ongoing||2013-002067-26||Difference between dosages needed of proton pump inhibitors for females and males||not-yet-due|
|Not reported||2015-002230-41||Pharmacokinetics of Proton Pump Inhibitors in a random Icelandic Population.||2017-03-31||due-trials|
|Ongoing||2017-004785-10||Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM): A nationwide phase 2 trial of patients with smoldering and active multiple myeloma (MM)||not-yet-due|